Seminars in Roentgenology
Volume 42, Issue 4 , Pages 218-227 , October 2007

Percutaneous Breast Biopsy: Emerging Techniques and Continuing Controversies

  • Liane E. Philpotts, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Liane E. Philpotts, MD, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208042, New Haven, CT 06520-8042.

References 

  1. Lannin DR, Ponn T, Andrejeva L, et al. Should all breast cancers be diagnosed by needle biopsy?. Am J Surg. 2006;192:450–454
  2. Bassett LW. The valuable role of the women’s imaging section in AJR: breast imaging. AJR Am J Roentgenol. 2006;187:948
  3. Mainiero MB, Gareen IF, Bird CE, et al. Preferential use of sonographically guided biopsy to minimize patient discomfort and procedure time in a percutaneous image-guided breast biopsy program. J Ultrasound Med. 2002;21:1221–1226
  4. Philpotts LE, Hooley RJ, Lee CH. Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2003;180:347–351
  5. Crystal P, Koretz M, Shcharynsky S, et al. Accuracy of sonographically guided 14-gauge core-needle biopsy: results of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions. J Clin Ultrasound. 2005;33:47–52
  6. Mercado CL, Goth AA, Axelrod D, et al. Does sonographically guided clip placement facilitate confirmation of removal of mammographically occult lesions after localization?. (abstr) AJR Am J Roentgenol. 2007;188:A33
  7. Patterson SK, Joe A, Helvie MA. Songraphically guided metallic clip placement at time of wire localization for subtle or occult mammographic lesions: A method to verify lesion retrieval (abstr). AJR Am J Roentgenol. 2007;188:A34
  8. Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997;204:485–488
  9. Liberman L, Smolkin JH, Dershaw DD, et al. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology. 1998;208:251–260
  10. Liberman L, Sama MP. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2000;175:53–58
  11. Pfarl G, Helbich TH, Riedl CC, et al. Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study. AJR Am J Roentgenol. 2002;179:1503–1507
  12. Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer. 2006;107:945–949
  13. Philpotts LE, Lee CH, Horvath LJ, et al. Underestimation of breast cancer with II-gauge vacuum suction biopsy. AJR Am J Roentgenol. 2000;175:1047–1050
  14. Brem RF, Behrndt VS, Sanow L, et al. Atypical ductal hyperplasia: Histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol. 1999;172:1405–1407
  15. Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology. 2002;224:548–554
  16. Winchester DJ, Bernstein JR, Jeske JM, et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg. 2003;138:619–622
  17. Pandelidis S, Heiland D, Jones D, et al. Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions (Erratum appears in Ann Surg Oncol 2003;10(3):330. [note: Heilman, D corrected to Heiland D]). Ann Surg Oncol. 2003;10:43–47
  18. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology. 2001;218:497–502
  19. Liberman L, Kaplan JB, Morris EA, et al. To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vac-uum-assisted breast biopsy?. (see comment) AJR Am J Roentgenol. 2002;179:679–683
  20. Brem RF, Schoonjans JM, Goodman SN, et al. Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices. Radiology. 2001;219:793–796
  21. Lifrange E, Dondelinger RF, Quatresooz P, et al. Stereotactic breast biopsy with an 8-gauge, directional, vacuum-assisted probe: initial experience. Eur Radiol. 2002;12:2180–2187
  22. Philpotts LE, Watson AN, Lee CH. Significance of “atypia” found on needle biopsy of the breast: correlation with surgical outcome and mammographic, biopsy, and clinical factors. (abstr) Radiological Society of North American Scientific Assembly and Annual Meeting Program. Oak Brook, IL: Radiological Society of North America; 2004;
  23. LaTrenta LR, Menell JH, Morris EA, et al. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology. 2003;227:856–861
  24. Perlet C, Schneider P, Amaya B, et al. MR-guided vacuum biopsy of 206 contrast-enhancing breast lesions. ROFO Fortschr Geb Rontgenstr Nuklearmed. 2002;174:88–95
  25. Liberman L, Bracero N, Morris E, et al. MRI-guided 9-gauge vacuum-assisted breast biopsy: Initial clinical experience. AJR Am J Roentgenol. 2005;185:183–193
  26. Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. (see comment) AJR Am J Roentgenol. 2002;178:1211–1220
  27. Stewart ST, Daftary A, Philpotts LE, et al. MR-guided needle localization biopsies of the breast: histologic outcome and miss rate. (abstr) Radiological Society of North American Scientific Assembly and Annual Meeting Program. Oak Brook, IL: Radiological Society of North America; 2004;
  28. Erguvan-Dogan B, Whitman GJ, Nguyen VA, et al. Specimen radiography in confirmation of MRI-guided needle localization and surgical excision of breast lesions. AJR Am J Roentgenol. 2006;187:339–344
  29. Morris E, Liberman L. Breast MRI: diagnosis and intervention. In: New York, NY: Springer; 2005;p. 280–286
  30. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. (see comment) Radiology. 1995;196:115–122
  31. Kuhl CK, Morakkabati N, Leutner CC, et al. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001;220:31–39
  32. Chen X, Lehman CD, Dee KE. MRI-guided breast biopsy: clinical experience with 14-gauge stainless steel core biopsy needle. AJR Am J Roentgenol. 2004;182:1075–1080
  33. Perlet C, Heinig A, Prat X, et al. Multicenter study for the evaluation of a dedicated biopsy device for MR-guided vacuum biopsy of the breast. Eur Radiol. 2002;12:1463–1470
  34. Ghate SV, Rosen EL, Soo MS, et al. MRI-guided vacuum-assisted breast biopsy with a handheld portable biopsy system. AJR Am J Roentgenol. 2006;186:1733–1736
  35. Lehman CD, Deperi ER, Peacock S, et al. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2005;184:1782–1787
  36. Orel SG, Rosen M, Mies C, et al. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Radiology. 2006;238:54–61
  37. Liberman L, Holland AE, Marjan D, et al. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2007;188:684–690
  38. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 2001;218:503–509
  39. Renshaw AA, Cartagena N, Derhagopian RP, et al. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol. 2002;117:797–799
  40. Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology. 2000;216:831–837
  41. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173:291–299
  42. Irfan K, Brem RF. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J. 2002;8:230–233
  43. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med. 2002;126:697–701
  44. Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. (see comment) Radiology. 2004;231:813–819
  45. Cohen MA. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. (comment) Radiology. 2004;231:617–621
  46. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 2006;187:949–954
  47. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001;176:1255–1259
  48. Frouge C, Tristant H, Guinebretiere JM, et al. Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology. 1995;195:623–625
  49. Jackman RJ, Nowels KW, Rodriguez-Soto J, et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. (see comment) Radiology. 1999;210:799–805
  50. Meyer JE, Smith DN, Lester SC, et al. Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy. Radiology. 1998;206:717–720
  51. Brenner RJ, Jackman RJ, Parker SH, et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?. (see comment) AJR Am J Roentgenol. 2002;179:1179–1184
  52. Lam WW, Chu WC, Tang AP, et al. Role of radiologic features in the management of papillary lesions of the breast. AJR Am J Roentgenol. 2006;186:1322–1327
  53. Gendler LS, Feldman SM, Balassanian R, et al. Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy. Am J Surg. 2004;188:365–370
  54. Page DL, Salhany KE, Jensen RA, et al. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78:258–266
  55. Tavassoli FA, Schnitt SJ. Pathology of the Breast. New York, NY: Elsevier; 1992;
  56. Liberman L, Bracero N, Vuolo MA, et al. Percutaneous large-core biopsy of papillary breast lesions. AJR Am J Roentgenol. 1999;172:331–337
  57. Mercado CL, Hamele-Bena D, Singer C, et al. Papillary lesions of the breast: evaluation with stereotactic directional vacuum-assisted biopsy. Radiology. 2001;221:650–655
  58. Rosen EL, Bentley RC, Baker JA, et al. Imaging-guided core needle biopsy of papillary lesions of the breast. AJR Am J Roentgenol. 2002;179:1185–1192
  59. Mercado CL, Hamele-Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology. 2006;238:801–808
  60. Liberman L, Tornos C, Huzjan R, et al. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?. AJR Am J Roentgenol. 2006;186:1328–1334
  61. Dennis MA, Parker S, Kaske TI, et al. Incidental treatment of nipple discharge caused by benign intraductal papilloma through diagnostic mammotome biopsy. AJR Am J Roentgenol. 2000;174:1263–1268

PII: S0037-198X(07)00041-7

doi: 10.1053/j.ro.2007.07.001

Seminars in Roentgenology
Volume 42, Issue 4 , Pages 218-227 , October 2007